"10.1371_journal.pone.0055785","plos one","2013-02-07T00:00:00Z","Molly Plovanich; Roman L Bogorad; Yasemin Sancak; Kimberli J Kamer; Laura Strittmatter; Andrew A Li; Hany S Girgis; Satya Kuchimanchi; Jack De Groot; Lauren Speciner; Nathan Taneja; Jonathan OShea; Victor Koteliansky; Vamsi K Mootha","Departments of Molecular Biology and Medicine, Massachusetts General Hospital, and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America; Broad Institute, Cambridge, Massachusetts, United States of America; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, United States of America","Performed computational analysis: AAL. Designed, validated and produced siRNA reagents: RLB SK JDG L. Speciner NT JO VK. Conceived and designed the experiments: MP VKM RLB YS KJK L. Strittmatter HSG. Performed the experiments: MP RLB YS KJK L. Strittmatter HSG. Analyzed the data: MP RLB YS KJK L. Strittmatter HSG. Wrote the paper: MP VKM.","Please note that in this paper, the authors' academic laboratory (based at Massachusetts General Hospital/Harvard Medical School) collaborated with Alnylam Pharmaceuticals (co-authors include JDG, L. Speciner, NT, JO, VK). As employees, they received compensation/stock from Alnylam. The authors do not believe that the fact that they are employees of a company, receiving salary/equity from this company, represents a competing interest that compromises the objectivity of the work. This does not alter the authors' adherence to all the PLOS ONE policies on data sharing and materials.","2013","02","Molly Plovanich","MP",14,TRUE,6,1,5,2,TRUE,TRUE,TRUE,4,"7;11;12;13",TRUE
